Clinical Trials
4 trialsNCT00020202 2024-03-04
FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01445340 2019-12-17
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT00048334 2019-12-12
Depsipeptide to Treat Thyroid and Other Advanced Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01353664 2019-11-25
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
Celgene
Phase 2 Completed